NEW YORK, NY, Apr 23, 2014 (Marketwired via COMTEX) — Cannabis Therapy Corp. (OTCQB: CTCO) (the “Company”) a development stage enterprise focused on the business of manufacturing and marketing pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of cannabis, for the treatment of various conditions and diseases, is pleased to confirm and welcomes the senior executive level appointment of Ms. Vered Caplan to its Board of Directors.
http://bit.ly/1lEVqAA
No comments:
Post a Comment